Data | Título | Autor(es) | Tipo | Acesso |
15-Nov-2010 | MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX/stem cell gene signature | Gaspar, Nathalie; Marshall, Lynley; Perryman, Lara, et al. | Artigo | Acesso aberto |
Set-2011 | Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma | Butowski, Nicholas; Chang, Susan M.; Lamborn, Kathleen R., et al. | Artigo | Acesso restrito UMinho |
2010 | Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation : a Portuguese multicentre study | Costa, Bruno Marques; Caeiro, Cláudia; Guimarães, Inês, et al. | Artigo | Acesso aberto |
20-Fev-2015 | A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide | Pojo, Marta; Gonçalves, Céline S.; Magalhães, Ana Xavier, et al. | Artigo | Acesso aberto |